Beware What You Say To The FDA
In Intendis v Glenmark , the Federal Circuit affirmed a finding of infringement under the doctrine of equivalents based on statements made by Glenmark to the FDA. The issue was whether isopropyl myristate in Glenmark’s formulation was equivalent to…
October 9, 2016Pharma & ANDA2 min read